QBench

QBench is a cloud-based Laboratory Information Management System (LIMS) provider that delivers an integrated Lab Operating System for testing laboratories across multiple industries. The company's platform combines LIMS functionality with Quality Management System, inventory management, billing, and customer portal capabilities in a single unified solution.

Founded in 2015 (some sources indicate 2016), QBench is a bootstrapped private company headquartered in Newark, Delaware. The company has grown to 30 employees across 4 continents, including North America, Asia, and Europe, as of 2025. Leadership is provided by CEO Nicholas Evans.

QBench serves testing labs in materials & manufacturing, food & beverage, life sciences/biotech, agriculture, and environmental testing sectors. The platform emphasizes ease of use, flexibility, and modern cloud-native architecture.

QBench has G2 recognition as the "#1 LIMS on G2's Highest Rated & Easiest to Use Lists," with awards including Momentum Leader, Best Results, Best Relationship, and High Performer designations across small business and mid-market segments in Spring 2025.

QBench is not a pharma-specialized vendor. Life sciences and biotechnology laboratories are one segment within a broader multi-industry LIMS offering that also serves materials & manufacturing, food & beverage, agriculture, and environmental testing labs. The platform supports FDA 21 CFR Part 11, GMP, GLP, and GxP requirements through its integrated Quality Management System and compliance features.

Total customer count is undisclosed. No pharmaceutical customer names appear on the public website. Case studies reference customers Light Labs and 34 Lives; neither case study specifies an industry sector. The company's blog carries educational content on 21 CFR Part 11 and GxP compliance.

QBench's compliance capabilities — 21 CFR Part 11, GxP, electronic signatures, audit trails — suit regulated pharmaceutical laboratories. The company targets small to mid-sized testing labs across multiple industries; large pharmaceutical manufacturers are not named as a target segment.

QBench is bootstrapped, per Crunchbase: no external funding, venture capital, or private equity investment has been reported. The company operates on a subscription-based revenue model.

Revenue estimates vary across sources. As of July 2025, one source reported annual revenue of $1.8 million; another stated $4 million in annual revenue for 2025. Specific financial metrics beyond these estimates are undisclosed.

No mergers, acquisitions, or other corporate development activity has been disclosed.

QBench sells one platform, QBench LIMS, marketed as an integrated Lab Operating System. It combines LIMS functionality (sample tracking, workflow automation, test management, results reporting) with a Quality Management System (equipment management, document control, training, SOP management, issues & logs), inventory management, billing & invoicing, and a customer web portal in a single cloud-based solution.

The platform is cloud-native SaaS. Configuration of workflows and reports is visual and point-and-click rather than requiring coding. QBench markets transparent pricing. G2 recognizes QBench as "Easiest to Use LIMS." The platform provides a REST API for integrations and supports automated instrument data syncing.

Innovation focus is on usability and integration rather than advanced AI or complex analytics. The platform integrates with business intelligence tools (Microsoft Power BI, Domo, Tableau) for customers who need advanced analytics capabilities.

QBench integrates with Microsoft Power BI, Domo, and Tableau for analytics and reporting, and with QuickBooks for billing and invoicing workflows. The platform provides a REST API for custom integrations, available to customers and third-party developers without a formal partnership program.

Implementation partners, consulting alliances, and industry affiliations — such as ISPE, PDA, or other pharmaceutical industry organizations — are undisclosed. The underlying cloud infrastructure provider is undisclosed.

QBench offers support through knowledge base, email/help desk, and phone support, per third-party software review sites. Customer support receives positive mentions in user reviews, with users citing vendor responsiveness as a strength.

Support availability — 24/7 coverage, regional support teams, multilingual support — is undisclosed. Implementation services, validation assistance, and professional consulting availability are undisclosed. Training covers platform usage.

User communities, annual conferences, certification programs, and customer success programs are undisclosed.

QBench received seven awards in G2's Spring 2025 LIMS category: Momentum Leader #1, Best Results #1, Best Relationship #1, High Performer Small Business #1, High Performer Mid-Market #1, Highest Rated LIMS, and Easiest to Use LIMS. The platform holds a 4.5/5 rating across 113 G2 reviews; over 95% of reviews come from North America customers.

Certification status (ISO 9001, ISO 27001, SOC 2) is undisclosed.

Leadership information is limited to CEO Nicholas Evans. The founding team, executive backgrounds, and advisory board are undisclosed.

Blog content includes posts on regulatory topics such as FDA 21 CFR Part 11 and GxP compliance.

QBench's website carries educational blog content on regulatory compliance topics, product information, and content comparing QBench to competitors including LabWare, LabVantage, and STARLIMS. The resource center includes blog posts, comparison guides, and at least one case study. Demo options are available; free trials are not offered, per third-party review sites. The content strategy focuses on educating prospects about LIMS selection and regulatory compliance.

Social media presence and engagement levels are undisclosed. Press release frequency and recent news coverage are undisclosed.

QBench has achieved top rankings on G2. Broader market awareness beyond G2 is limited: the company does not appear in Gartner Magic Quadrants or other major analyst reports.